296 related articles for article (PubMed ID: 32885297)
1. Added-value of advanced magnetic resonance imaging to conventional morphologic analysis for the differentiation between benign and malignant non-fatty soft-tissue tumors.
Dodin G; Salleron J; Jendoubi S; Abou Arab W; Sirveaux F; Blum A; Gondim Teixeira PA
Eur Radiol; 2021 Mar; 31(3):1536-1547. PubMed ID: 32885297
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic performance of diffusion-weighted (DWI) and dynamic contrast-enhanced (DCE) MRI for the differentiation of benign from malignant soft-tissue tumors.
Choi YJ; Lee IS; Song YS; Kim JI; Choi KU; Song JW
J Magn Reson Imaging; 2019 Sep; 50(3):798-809. PubMed ID: 30663160
[TBL] [Abstract][Full Text] [Related]
3. Differentiation of Benign From Malignant Sinonasal Masses Using Diffusion Weighted Imaging and Dynamic Contrast Enhanced Magnetic Resonance Imaging.
Daga R; Kumar J; Pradhan G; Meher R; Malhotra V; Khurana N
Am J Rhinol Allergy; 2022 Mar; 36(2):207-215. PubMed ID: 34486401
[TBL] [Abstract][Full Text] [Related]
4. Characterization of indeterminate soft tissue masses referred for biopsy: What is the added value of contrast imaging at 3.0 tesla?
Del Grande F; Ahlawat S; Subhawong T; Fayad LM
J Magn Reson Imaging; 2017 Feb; 45(2):390-400. PubMed ID: 27417663
[TBL] [Abstract][Full Text] [Related]
5. Usefulness of diffusion-weighted MR imaging for differentiating between benign and malignant superficial soft tissue tumours and tumour-like lesions.
Jeon JY; Chung HW; Lee MH; Lee SH; Shin MJ
Br J Radiol; 2016; 89(1060):20150929. PubMed ID: 26892266
[TBL] [Abstract][Full Text] [Related]
6. Differentiation of malignant from benign soft tissue tumours: use of additive qualitative and quantitative diffusion-weighted MR imaging to standard MR imaging at 3.0 T.
Lee SY; Jee WH; Jung JY; Park MY; Kim SK; Jung CK; Chung YG
Eur Radiol; 2016 Mar; 26(3):743-54. PubMed ID: 26080796
[TBL] [Abstract][Full Text] [Related]
7. Multiparametric breast MRI with 3T: Effectivity of combination of contrast enhanced MRI, DWI and 1H single voxel spectroscopy in differentiation of Breast tumors.
Aribal E; Asadov R; Ramazan A; Ugurlu MÜ; Kaya H
Eur J Radiol; 2016 May; 85(5):979-86. PubMed ID: 27130059
[TBL] [Abstract][Full Text] [Related]
8. Do contrast-enhanced and advanced MRI sequences improve diagnostic accuracy for indeterminate lipomatous tumors?
Shannon BA; Ahlawat S; Morris CD; Levin AS; Fayad LM
Radiol Med; 2022 Jan; 127(1):90-99. PubMed ID: 34697728
[TBL] [Abstract][Full Text] [Related]
9. Multiparametric quantitative analysis of tumor perfusion and diffusion with 3T MRI: differentiation between benign and malignant soft tissue tumors.
Lee SK; Jee WH; Jung CK; Chung YG
Br J Radiol; 2020 Nov; 93(1115):20191035. PubMed ID: 32649224
[TBL] [Abstract][Full Text] [Related]
10. Characterization of parotid gland tumors: added value of permeability MR imaging to DWI and DCE-MRI.
Yabuuchi H; Kamitani T; Sagiyama K; Yamasaki Y; Hida T; Matsuura Y; Hino T; Murayama Y; Yasumatsu R; Yamamoto H
Eur Radiol; 2020 Dec; 30(12):6402-6412. PubMed ID: 32613285
[TBL] [Abstract][Full Text] [Related]
11. Differentiation between orbital malignant and benign tumors using intravoxel incoherent motion diffusion-weighted imaging: Correlation with dynamic contrast-enhanced magnetic resonance imaging.
Xu XQ; Hu H; Su GY; Liu H; Wu FY; Shi HB
Medicine (Baltimore); 2019 Mar; 98(12):e14897. PubMed ID: 30896639
[TBL] [Abstract][Full Text] [Related]
12. Qualitative characterization of breast tumors with diffusion-weighted imaging has comparable accuracy to quantitative analysis.
Kul S; Metin Y; Bekircavusoglu S; Kul M
Clin Imaging; 2021 Sep; 77():17-24. PubMed ID: 33639496
[TBL] [Abstract][Full Text] [Related]
13. Intravoxel incoherent motion diffusion-weighted imaging as an adjunct to dynamic contrast-enhanced MRI to improve accuracy of the differential diagnosis of benign and malignant breast lesions.
Ma D; Lu F; Zou X; Zhang H; Li Y; Zhang L; Chen L; Qin D; Wang B
Magn Reson Imaging; 2017 Feb; 36():175-179. PubMed ID: 27742437
[TBL] [Abstract][Full Text] [Related]
14. Role of diffusion weighted imaging and magnetic resonance spectroscopy in breast cancer patients with indeterminate dynamic contrast enhanced magnetic resonance imaging findings.
Sharma U; Agarwal K; Hari S; Mathur SR; Seenu V; Parshad R; Jagannathan NR
Magn Reson Imaging; 2019 Sep; 61():66-72. PubMed ID: 31128225
[TBL] [Abstract][Full Text] [Related]
15. Magnetic resonance imaging biomarkers in musculoskeletal soft tissue tumors: Review of conventional features and focus on nonmorphologic imaging.
Ahlawat S; Fritz J; Morris CD; Fayad LM
J Magn Reson Imaging; 2019 Jul; 50(1):11-27. PubMed ID: 30793420
[TBL] [Abstract][Full Text] [Related]
16. Diffusion-Weighted Imaging With Apparent Diffusion Coefficient Mapping for Breast Cancer Detection as a Stand-Alone Parameter: Comparison With Dynamic Contrast-Enhanced and Multiparametric Magnetic Resonance Imaging.
Pinker K; Moy L; Sutton EJ; Mann RM; Weber M; Thakur SB; Jochelson MS; Bago-Horvath Z; Morris EA; Baltzer PA; Helbich TH
Invest Radiol; 2018 Oct; 53(10):587-595. PubMed ID: 29620604
[TBL] [Abstract][Full Text] [Related]
17. Assessment of breast mass morphology with diffusion-weighted MRI: Beyond apparent diffusion coefficient.
Kul S; Metin Y; Kul M; Metin N; Eyuboglu I; Ozdemir O
J Magn Reson Imaging; 2018 Dec; 48(6):1668-1677. PubMed ID: 29734493
[TBL] [Abstract][Full Text] [Related]
18. Added value of diffusion-weighted imaging to conventional MRI for predicting fascial involvement of soft tissue sarcomas.
Yoon MA; Chee CG; Chung HW; Song JS; Lee JS; Kim W; Lee MH; Lee SH; Shin MJ
Eur Radiol; 2019 Apr; 29(4):1863-1873. PubMed ID: 30324391
[TBL] [Abstract][Full Text] [Related]
19. The diagnostic value of combining conventional, diffusion-weighted imaging and dynamic contrast-enhanced MRI for salivary gland tumors.
Zheng N; Li R; Liu W; Shao S; Jiang S
Br J Radiol; 2018 Sep; 91(1089):20170707. PubMed ID: 29902075
[TBL] [Abstract][Full Text] [Related]
20. [The actions of diffusion weighted imaging (DWI) and dynamic contrast enhanced MRI in differentiating breast tumors].
Luo Y; Yu J; Chen D; Xu Z; Zeng H
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2013 Dec; 30(6):1219-23. PubMed ID: 24645600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
